7HUZhan-xing,AN Qiao,LI Kun-feng. Identification,Synthesis,and Strategy for Minimization of Potential Impurities in the Preclinical Anti-HBV Drug Y101[J].{H}Organic Process Research and Development,2013,(09):1156-1167.
8International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). Impurities in new drug substances Q3A (R2)[EB/OL].http://www.ich.org/products/guidelines/quality/article/quality-guideline s.html,2006.
